Celularity Inc. (CELUW) Technical Exchange News April 30, 2025, 01:42 UTC 14 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent. Comment Full text
Celularity Inc. (CELU) Technical Exchange News April 30, 2025, 01:42 UTC 17 NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent. Comment Full text
Vor Biopharma Inc (VOR) Technical Exchange News April 29, 2025, 19:20 UTC 14 NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Quoin Pharmaceuticals Ltd DRC (QNRX) Technical Exchange News April 29, 2025, 19:20 UTC 15 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
P3 Health Partners Inc (PIII) Technical Exchange News April 29, 2025, 19:20 UTC 15 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Celularity Inc. (CELU) Technical Exchange News April 29, 2025, 19:19 UTC 15 NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent. Comment Full text
Celularity Inc. (CELUW) Technical Exchange News April 29, 2025, 19:19 UTC 16 NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent. Comment Full text
Amarin Corporation Plc (AMRN) Technical Exchange News April 29, 2025, 19:19 UTC 8 NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Aerovate Therapeutics Inc (AVTE) Technical Exchange News April 29, 2025, 08:06 UTC 9 Aerovate Therapeutics Inc (AVTE) was removed from the list of traded instruments on NASDAQ exchange Comment Full text
Spruce Biosciences Inc (SPRB) Technical Exchange News April 29, 2025, 08:06 UTC 9 Spruce Biosciences Inc (SPRB) was removed from the list of traded instruments on NASDAQ exchange Comment Full text